விசை இரசாயன தொகுப்பு அடிப்படையிலானது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விசை இரசாயன தொகுப்பு அடிப்படையிலானது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விசை இரசாயன தொகுப்பு அடிப்படையிலானது Today - Breaking & Trending Today

Sadhana Nitro Chem update on launch of Para Amino Phenol

Sadhana Nitro Chem announced that the company has received approval for its application under Production Linked Incentive (PLI) Scheme from IFCI no behalf of the Department of Pharmaceuticals for the production of Para Amino Phenol (PAP) and is under the segment Key Chemical Synthesis Based KSMs/Drug Intermediates.
Additionally, due to the present pandemic situation, while the installation of the PAP plant continues to be ongoing, there have been resultant delays pushing the commercial launch date.
The first phase of the plant is expected to go live in July, 2021 and second phase in August, 2021.
Powered by Capital Market - Live News ....

Department Of Pharmaceuticals , Sadhana Nitro Chem , Production Linked Incentive , Para Amino Phenol , Key Chemical Synthesis Based , Capital Market , Physical Sciences , Functional Groups , Natural Sciences , Ifci Ltd , Orporate Financial Services Nec , Commodity Chemicals Nec , Sadhana Nitro Chem , Map Plant , Department Of Pharmaceuticals , துறை ஆஃப் மருந்துகள் , சாதனா நைட்ரோ செம் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , விசை இரசாயன தொகுப்பு அடிப்படையிலானது , மூலதனம் சந்தை ,

Sadhana Nitro Chem Limited updates on Para Amino Phenol (PAP) plant

Sadhana Nitro Chem Limited updates on Para Amino Phenol (PAP) plant
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

New Delhi , Cibil Transunion , Department Of Pharmaceuticals , Sadhana Nitro Chem Limited The Company , Sadhana Nitro Chem , High Court , Nitro Chem Limited , Para Amino Phenol , Time Zone , Production Linked Incentive , India Undertaking , Key Chemical Synthesis Based , புதியது டெல்ஹி , துறை ஆஃப் மருந்துகள் , சாதனா நைட்ரோ செம் , உயர் நீதிமன்றம் , நேரம் ஸோந் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , இந்தியா மேற்கொள்வது , விசை இரசாயன தொகுப்பு அடிப்படையிலானது ,

Aarti Drugs' unit gets approval under pharma PLI scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30. ....

Adhish Patil , Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Chief Financial Officer , Pharma Intermediates , Capital Market , Pharmaceutical Industry In China , Pharmaceuticals Policy , Pharmacy In China , Science And Technology In The Peoples Republic Of China , Chemical Substance , Physical Sciences , Natural Sciences , Companies Based In , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் ,

Moderate gains seen at open, but crude, FPI flow to anchor direction

Moderate gains seen at open, but crude, FPI flow to anchor direction
March 08, 2021
×
Asian markets in early trade on Monday are up 0.5-1.5%; US markets on Friday closed up 1.55-2%; analysts fear the market may see volatility
The Indian stock markets, after falling a couple of days, are expected to open on a positive note on Monday, thanks to global markets. The SGX Nifty, ruling at 15,080, points to a 130-point gain for Nifty futures, which on Friday closed at 14,953 on the NSE.
Asian markets in early trade on Monday are up in the range of between 0.5 and 1.5 per cent. Australian indices are ruling with the biggest gains on Monday, while China, Japan and Taiwan too are firm. The US markets on Friday too closed up 1.55-2 per cent. ....

Nishant Pitti , Rikant Pittie , Warburg Pincus , Vinod Nair , India Grid , Bioproducts Pty Ltd , Windy Lakeside Investment Ltd , Department Of Pharmaceuticals , Just Dial , Tata Motors , Indian Premier League , Union Territory , Head Of Research At Geojit Financial Services , Sun Pharmaceutical Industries , Aarti Speciality Chemicals Limited , Ashok Leyland , Gera Developments Private , Ministry Of Chemicals , Star India Private Limited , Geojit Financial , Bharat Forge , Megha Engineering , Adani Ports , Grid Trust , Sterlite Power , Aarti Drugs ,

Aarti Drugs' unit benefits from Govt.'s PLI Scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. ....

Government Of India Department Pharmaceuticals , Ministry Of Chemicals , Aarti Speciality Chemicals , Aarti Drugs , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Active Pharmaceutical Ingredients , Target Segments , Speciality Chemicals , Target Segment , Key Chemical Synthesis Based , Drug Intermediates , Capital Market , Indian Films , Pharmaceuticals Nec , Government Of Indias Department Pharmaceuticals , Government Of India , Pharmaceutical Manufacturers , Ministry Of Chemicals And Fertilizers , அரசு ஆஃப் இந்தியா துறை மருந்துகள் , அமைச்சகம் ஆஃப் இரசாயனங்கள் , ஆர்த்தி சிறப்பு இரசாயனங்கள் , ஆர்த்தி மருந்துகள் , ப்ரொடக்ஶந் இணைக்கப்பட்டுள்ளது ஊக்கத்தொகை , இரசாயன தொகுப்பு ,